WADA - COVID-19: Athlete Q&A - Version 2

COVID-19 : Athlete Q&A / World Anti-Doping Agency (WADA). - Montreal : WADA, 2020
_________________________________________________

The World Anti-Doping Agency (WADA) has published a Question and Answer (Q&A) document related to anti-doping and COVID-19, which is an update to the document that the Agency published on 23 March 2020. Once again, it was developed in consultation with WADA’s Athlete Committee.

The updated Q&A covers matters such as:

- Testing during COVID-19
- Minimizing the risk of contracting or transmitting the virus
- Filing of whereabouts information
- Validating Therapeutic Use Exemptions
- Maintaining the integrity of the global anti-doping system
- Refusing to comply with testers at this time
- Confidence in the anti-doping system

WADA will continue to liaise with athletes and Anti-Doping Organizations in the interest of publishing updates regarding the Agency’s response to COVID-19 as the situation evolves.

Original document

Parameters

Date
25 May 2020
Original Source
World Anti-Doping Agency (WADA)
Country
Canada
Language
English
ADRV
Refusal or failure to submit to sample collection
Whereabouts
Legal Terms
Code compliance
International Standard for Testing and Investigations (ISTI)
WADA Code, Guidelines, Protocols, Rules & Regulations
Other organisations
World Anti-Doping Agency (WADA)
Medical terms
COVID-19
Therapeutic Use Exemption (TUE)
Various
Contamination
Doping control
Education
Sample collection procedure
Document category
Rules / Regulations
Document type
Pdf file
Date generated
27 May 2020
Date of last modification
10 June 2020
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin